HomeXBIT • NASDAQ
add
XBiotech Inc
Nakaraang pagsara
$2.31
Sakop ng araw
$2.29 - $2.33
Sakop ng taon
$2.09 - $3.62
Market cap
70.12M USD
Average na Volume
33.58K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Mga balita tungkol sa merkado
MarketWatch
12 minuto ang nakalipas
Why fund managers may be caught off guard by a ‘ripper of a rally’
0.00%
Mga Financial
Income Statement
Kita
Net na kita
| (USD) | Dis 2025info | Y/Y na pagbabago |
|---|---|---|
Kita | — | — |
Gastos sa pagpapatakbo | 29.76M | 240.13% |
Net na kita | -26.89M | -155.92% |
Net profit margin | — | — |
Kita sa bawat share | — | — |
EBITDA | -29.38M | -253.56% |
Aktuwal na % ng binabayarang buwis | -0.28% | — |
Balance Sheet
Kabuuang asset
Kabuuang sagutin
| (USD) | Dis 2025info | Y/Y na pagbabago |
|---|---|---|
Cash at mga panandaliang investment | 125.55M | -27.29% |
Kabuuang asset | 150.08M | -24.62% |
Kabuuang sagutin | 9.73M | -42.16% |
Kabuuang equity | 140.35M | — |
Natitirang share | 30.49M | — |
Presyo para makapag-book | 0.50 | — |
Return on assets | -46.13% | — |
Return on capital | -48.39% | — |
Cash Flow
Net change in cash
| (USD) | Dis 2025info | Y/Y na pagbabago |
|---|---|---|
Net na kita | -26.89M | -155.92% |
Cash mula sa mga operasyon | -22.95M | -250.95% |
Cash mula sa pag-invest | -34.00K | 59.52% |
Cash mula sa financing | 0.00 | -100.00% |
Net change in cash | -21.82M | -108.95% |
Malayang cash flow | -13.54M | -136.67% |
Tungkol
XBiotech Inc. is a clinical-stage biopharmaceutical company based in Austin, Texas. It specializes in the research and development of human-derived antibody therapeutics for multiple diseases, including cancer, rheumatological, and infectious diseases. Wikipedia
Itinatag
2005
Headquarters
Website
Mga Empleyado
88
